Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
98.56
-0.25 (-0.25%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Zimmer Biomet Holdings Stock Forecast

Stock Price Forecast

According to 28 analysts polled by S&P Global, Zimmer Biomet Holdings stock has a consensus rating of "Buy" and an average price target of $106.82. The average 1-year stock price forecast is 8.38% higher than the current stock price, while the lowest is $93 (-5.64%) and the highest is $130 (+31.90%).

Price Target: $106.82 (+8.38%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$93$106.82$105$130
Change-5.64%+8.38%+6.53%+31.90%

Analyst Ratings

The average analyst rating for Zimmer Biomet Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy666666
Buy223333
Hold171718181819
Sell000000
Strong Sell110000
Total262627272728

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Argus Research
Argus Research
Buy
Reiterates
$125
BuyReiterates$125+26.83%Oct 22, 2026
Leerink Partners
Leerink Partners
Hold
Reiterates
$106 → $97
HoldReiterates$106 → $97-1.58%Oct 12, 2026
BTIG
BTIG
Hold
Maintains
n/a
HoldMaintainsn/an/aOct 9, 2026
Barclays
Barclays
Hold
Initiates
$100
HoldInitiates$100+1.46%Oct 7, 2026
Citi
Citi
Hold
Maintains
$99
HoldMaintains$99+0.45%Oct 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
8.60B
from 8.23B
Increased by 4.43%
Revenue Next Year
8.90B
from 8.60B
Increased by 3.54%
EPS This Year
8.53
from 8.20
Increased by 4.07%
EPS Next Year
9.05
from 8.53
Increased by 6.06%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
6.83B6.94B7.39B7.68B8.23B8.60B
Revenue Growth
11.42%1.65%6.55%3.85%7.20%4.43%
Gross Profit
4.87B4.92B5.32B5.50B5.74B6.11B
Gross Margin
71.29%70.90%71.93%71.61%69.71%71.11%
Operating Income
1.22B1.29B1.51B1.59B1.40B2.31B
Net Income
401.60M231.40M1.02B903.80M705.10M929.49M
EPS
----8.208.53
EPS Growth
----2.50%4.07%
Forward PE
16.4018.6315.4712.5210.7211.55
Dividend / Share
0.960.960.960.960.960.99
Dividend Growth
-----3.41%
Free Cash Flow
----1.17B1.13B
No. Analysts
-----26
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High8.6B
Avg8.6B
Low8.5B

Revenue Growth

Revenue Growth202620272028
High
4.7%
Avg
4.4%
Low
3.9%

EPS Forecast

EPS202620272028
High8.57
Avg8.53
Low8.49

EPS Growth

EPS Growth202620272028
High
4.5%
Avg
4.1%
Low
3.5%